Short answer
ASP Isotopes Inc. (ASPI) filed its Q2 2026 10-Q quarterly report on Aug 14, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $5M (up 327.5% year over year) with net income of −$34M.
Q2 2026 key financials · XBRL
- Revenue
- $5M
- +327.5% YoY · +22.6% QoQ
- Net income
- −$34M
- +54.8% YoY · −377.4% QoQ
- Operating margin
- -667.5%
- Gross margin
- 28.9%
- EPS (diluted)
- −$0.27
- +74.3% YoY · −350.0% QoQ
Source: XBRL data from the ASP Isotopes Inc. (ASPI) Q2 2026 10-Q on SEC EDGAR. USD.
ASP Isotopes Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New merger-completion risk triggered by June 25, 2026 agreement, including ENDRA stockholder approval and S-4 effectiveness
- Merger termination deadline of December 24, 2026 if closing conditions remain unsatisfied
- Regulatory risk from required U.S. International Development Finance Corporation consent under Tetra4’s finance agreement
- Operational risk from delayed integration, key-employee loss, and customer relationship disruption
- Financing risk from Noble’s approximately $50 million investment and ENDRA’s minimum $3.8 million cash condition
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ASP Isotopes Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.